METHODS AND COMPOSITIONS FOR INDUCTION OF UCP1 EXPRESSION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15309320

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods and compositions for the induction of expression of UCP1 independent of lipid accumulation. The invention, in particular, features methods for converting FGF receptive cells, e.g., preadipocyte cells, into energy consuming cells through FGF-mediated UCP1 expression. The invention further provides methods and compositions for treating metabolic disorders with an FGF receptor agonist, (e.g., an FGF protein, or fragment thereof, a nucleic acid encoding an FGF protein, an FGF mimetic, an anti-FGF receptor agonist antibody, or antigen binding fragment thereof), or a cell contacted with an FGF receptor agonist, including FGF6.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOSLIN DIABETES CENTER INCONE JOSLIN PLACE BOSTON MA 02215

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kahn, C Ronald West Newton, US 30 199
Tseng, Yu-Hua Newton, US 17 109

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation